EGA joins forces with other players on universal access to health

5 May 2015

The European Generic and Biosimilar medicines Association (EGA) organized a roundtable on ‘Universal Access to Health, a year after the European Union elections’ today in Brussels together with the European Patients Forum, International Association of Mutual Benefit Societies and Doctors of the World.

Over 70 participants debated ways to ensure universal access to health care across the EU. This roundtable is the follow-up of a dialogue initiated a year ago on the occasion of the EU elections to exchange with EU politicians, national governments and the health care community to promote universal and equitable access for patients to quality healthcare.

The event was opened by Member of the European Parliament Karin Kadenbach and included active participation from MEPs Boleslaw Piecha, former Polish Vice Minister and Alojz Peterle, President of the European Parliament ‘MEPs against Cancer’ Interest Group and vice president of the European Parliament Aging and Intergenerational Solidarity Intergroup Subgroup on Active Aging.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Biosimilars